Initiator Pharma A/S

Initiator Pharma A/S is a Danish clinical stage life science company developing innovative drugs that target key unmet medical needs within the central and peripheral nervous system. Initiator Pharma’s pipeline consists of three clinical programs – the clinical programs IP2018 and IPED2015 for treatment of erectile dysfunction of psychogenic and organic origin, respectively, and the orphan drug program IPTN2021 for Trigeminal Neuralgia, a severe neuropathic pain condition.

Contact name:

Christina Guldberg

Address:

Ole Maaløes Vej 3, DK-2200 Copenhagen N

Telephone:

+45 30742915

Established:

2016

Number of employees:

3

If you cannot find what you are looking for or if you have feedback to our website, please do not hesitate to contact dd@danskbiotek.dk or +45 5150 0560

Copyright 2022 Danskbiotek. All rights reserved.